Glypressin 0,1 mg/ml Solution for Injection
PDF Leaflet Revision Date: 9 June 2016
Clinical Summary
Quick overview from the medicine insert
Indication
Bleeding oesophageal varices.
Dosage (summary)
Initial: 1.7 mg (2 ampoules) IV every 4 hours; adjust to 0.85 mg (1 ampoule) for <50 kg or adverse effects.
Onset of Action / Duration
Onset: 30 mins, Duration: 4 hours
Special Populations
- Elderly
- Paediatric
Pregnancy & Breastfeeding
Contraindicated in pregnancy; insufficient data for breastfeeding.
Key Drug Interactions
- Increased hypotensive effect with non-selective u03b2-blockers
- Bradycardia with beta-blockers
Contraindications
- Hypersensitivity to terlipressin
- Pregnancy
Common side effects
- Paleness
- Increased blood pressure
- Abdominal pain
- Nausea
- Diarrhoea
- Headache
Counselling Points
- Monitor for side effects
- Avoid in pregnancy
- Report any unusual symptoms immediately
Serious warnings
- Monitor blood pressure, heart rate, and fluid balance
- Risk of local necrosis if not given IV
- Caution in hypertension and heart disease
Important Disclaimer
The Glypressin 0,1 mg/ml Solution for Injection professional information leaflet below is the property of Ferring and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
